: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Thoracic Surgery

Free Subscription

Articles published in Catheter Cardiovasc Interv
Retrieve available abstracts of 488 articles:
HTML format

Single Articles

September 2023

SHAMKHANI W, Moledina S, Rashid M, Mamas MA, et al
Complex high-risk percutaneous coronary intervention types, trends, and outcomes according to vascular access site.
Catheter Cardiovasc Interv. 2023 Sep 26. doi: 10.1002/ccd.30846.
PubMed Abstract available

BARRETT CD, Nickel A, Rosenberg MA, Ream K, et al
PRIME score for prediction of permanent pacemaker implantation after transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2023 Sep 21. doi: 10.1002/ccd.30845.
PubMed Abstract available

SOUD M, Feit F, Rao S, Bangalore S, et al
Novel approach to stenting the left anterior descending coronary artery through a retrograde approach via the left internal mammary artery graft in a patient with occlusion of the coronary ostium from a prior aortic valve replacement.
Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30844.
PubMed Abstract available

ROTH N, Heidel C, Xu C, Hubauer U, et al
Restoration of von Willebrand factor after transcatheter aortic valve replacement-A possible cause for posttranscatheter aortic valve replacement thrombocytopenia?
Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30841.
PubMed Abstract available

DI MAIO M, Esposito L, Silverio A, Bellino M, et al
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2023 Sep 13. doi: 10.1002/ccd.30842.
PubMed Abstract available

AHN J, Yu H, Rha SW, Choi BG, et al
Long-term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions.
Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30829.
PubMed Abstract available

REMPAKOS A, Kostantinis S, Simsek B, Karacsonyi J, et al
Impact of preprocedural anemia on in-hospital and follow-up outcomes of chronic total occlusion percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30810.
PubMed Abstract available

HIRAI T, Grantham JA, Kandzari DE, Ballard W, et al
Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30834.
PubMed Abstract available

ALEXANDROU M, Rempakos A, Al Ogaili A, Choi JW, et al
Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.
Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30830.
PubMed Abstract available

SOMSEN YBO, de Winter RW, Giunta R, Schumacher SP, et al
Collateral grading systems in retrograde percutaneous coronary intervention of chronic total occlusions.
Catheter Cardiovasc Interv. 2023 Sep 6. doi: 10.1002/ccd.30812.
PubMed Abstract available

BRUNO F, Kang J, Elia E, Han JK, et al
Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.
Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30802.
PubMed Abstract available

VAZQUEZ DJL, Lopez GA, Guzman MQ, Cancelo AV, et al
Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
Catheter Cardiovasc Interv. 2023;102:513-520.
PubMed Abstract available

August 2023

KUNA C, Wiedenmayer N, Bradaric C, Presch A, et al
Ten-year outcomes after percutaneous coronary intervention of in-stent restenosis in saphenous vein grafts.
Catheter Cardiovasc Interv. 2023 Aug 21. doi: 10.1002/ccd.30807.
PubMed Abstract available

GUPTA R, Mahmoudi E, Behnoush AH, Malik AH, et al
Clinical outcomes and the impact of valve morphology for transcatheter aortic valve replacement in bicuspid aortic valves: A systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2023 Aug 21. doi: 10.1002/ccd.30808.
PubMed Abstract available

KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
Incidence, mechanisms, treatment, and outcomes of donor vessel injury during percutaneous coronary interventions for chronic total occlusion.
Catheter Cardiovasc Interv. 2023 Aug 10. doi: 10.1002/ccd.30798.
PubMed Abstract available

SUZUKI N
Prediction of residual ischemia after coronary stenting by quantitative flow ratio modulated by optical coherence tomography: Where we are now and our future perspectives.
Catheter Cardiovasc Interv. 2023;102:392-393.
PubMed

ZAHR F, Chadderdon S
Long-term results of M-TEER: A mountain of data with gaps to cross.
Catheter Cardiovasc Interv. 2023;102:400-401.
PubMed

LONG Y, Li W, Chen S, Li M, et al
Novel arm-width-expandable transcatheter edge-to-edge repair system: Preclinical experiment and first-in-human study.
Catheter Cardiovasc Interv. 2023;102:301-309.
PubMed Abstract available

July 2023

GROGER M, Zeiml KP, Schneider LM, Rottbauer W, et al
Impact of concomitant tricuspid regurgitation on outcome after edge-to-edge mitral valve repair.
Catheter Cardiovasc Interv. 2023 Jul 28. doi: 10.1002/ccd.30787.
PubMed Abstract available

ZHENG HJ, Yan CJ, Lin DQ, Cheng YB, et al
Prognostic impact of new permanent pacemaker implantation following transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30788.
PubMed Abstract available

KANDZARI DE, Garcia-Garcia HM, Stoler RC, Wang J, et al
Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30783.
PubMed Abstract available

ELBADAWI A, Dang AT, Hamed M, Ali A, et al
Transcatheter edge-to-edge repair for mitral regurgitation using PASCAL or MitraClip.
Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30772.
PubMed Abstract available

GINETE WL, Groth NA, Rudeck MN, Renier CM, et al
Outcomes of same-day discharge following percutaneous coronary intervention in a rural population.
Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30762.
PubMed Abstract available

PARK DY, An S, Jolly N, Attanasio S, et al
Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression.
Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30784.
PubMed Abstract available

AIJAZ B, Glorioso TJ, Butala N, Waldo SW, et al
Temporal trends and hospital variation in the use of P2Y12 inhibitors among patients undergoing percutaneous coronary intervention: Insights from the VA CART program.
Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30782.
PubMed

SONODA S, Node K
Fighting calcification with optical coherence tomography-guided percutaneous coronary intervention. Commentary on the optical coherence tomography-derived predictors of stent expansion in calcified lesions.
Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30776.
PubMed

KANE J, Kearney KE, Lombardi WL, Azzalini L, et al
Electrocautery-assisted re-entry to resolve bilateral aorto-ostial chronic total occlusions due to leaflet obstruction following transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30781.
PubMed Abstract available

GHIZZONI G, Ancona MB, Romano V, Bellini B, et al
Mind the "commissural drop" when crossing the aortic valve!
Catheter Cardiovasc Interv. 2023 Jul 18. doi: 10.1002/ccd.30763.
PubMed

NATALIS A, Masson JB, Mansour MJ, Asmar MA, et al
Correlation between measured and predicted mismatch with valve hemodynamics in transcatheter aortic valve replacement: A sex-based analysis.
Catheter Cardiovasc Interv. 2023 Jul 14. doi: 10.1002/ccd.30764.
PubMed Abstract available

ZAMORANO JL, Appleby C, Benamer H, Frankenstein L, et al
Improving access to transcatheter aortic valve implantation across Europe by restructuring cardiovascular services: An expert council consensus statement.
Catheter Cardiovasc Interv. 2023 Jul 11. doi: 10.1002/ccd.30760.
PubMed Abstract available

FAROUK H, Schone D, Witt C, Bayyud H, et al
Papillary muscle rupture after transcatheter aortic valve implantation: A case report and literature review.
Catheter Cardiovasc Interv. 2023 Jul 7. doi: 10.1002/ccd.30761.
PubMed Abstract available

LANG FM, Mihatov N, Kriegel J, Nazif TM, et al
Transcatheter aortic valve-in-valve implantation within stentless landing zones: Procedural insights from a single-center experience.
Catheter Cardiovasc Interv. 2023 Jul 2. doi: 10.1002/ccd.30755.
PubMed Abstract available

MITSUI K, Lee T, Miyazaki R, Hara N, et al
Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
Catheter Cardiovasc Interv. 2023;102:11-17.
PubMed Abstract available

June 2023

BLANKE P, Modine T, Duncan A, Taramasso M, et al
Anatomic suitability for transapical transcatheter mitral valve implantation using a tether-based device.
Catheter Cardiovasc Interv. 2023 Jun 24. doi: 10.1002/ccd.30752.
PubMed Abstract available

REZKALLA J, Reddy Y, Nishimura RA, Padang R, et al
Right heart catheterization predictors of symptomatic improvement in patients undergoing transcatheter tricuspid valve edge-to-edge repair.
Catheter Cardiovasc Interv. 2023 Jun 23. doi: 10.1002/ccd.30754.
PubMed Abstract available

YOKOYAMA H, Ochiai T, Saito S
Infective endocarditis after transcatheter edge-to-edge repair for severe mitral regurgitation; a case report and a systematic review.
Catheter Cardiovasc Interv. 2023 Jun 21. doi: 10.1002/ccd.30751.
PubMed Abstract available

PICCOLO R, Leone A, Simonetti F, Avvedimento M, et al
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2023 Jun 19. doi: 10.1002/ccd.30749.
PubMed Abstract available

LOPEZ-MINGUEZ JR, Martin de Francisco AL, Soler MJ, Hernandez F, et al
Cost-effectiveness analysis of dyevert Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain.
Catheter Cardiovasc Interv. 2023 Jun 10. doi: 10.1002/ccd.30744.
PubMed Abstract available

AURIGEMMA C, Trani C, D'Errigo P, Barbanti M, et al
Impact of vascular complications after transcatheter aortic valve implantation. VASC-OBSERVANT II sub-study.
Catheter Cardiovasc Interv. 2023 Jun 2. doi: 10.1002/ccd.30695.
PubMed Abstract available

DE LA TORRE HERNANDEZ JM, Veiga Fernandez G, Barrera S, Sainz Laso F, et al
Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation.
Catheter Cardiovasc Interv. 2023;101:1214-1220.
PubMed Abstract available

PERSHAD A
CTO revascularization in TAVR patients-The jury is still out.
Catheter Cardiovasc Interv. 2023;101:1229.
PubMed

MERDLER I, Bernardo NL, Ben-Dor I, Waksman R, et al
Cutting balloon for femoral arterial and venus obstructions due to suture-based closure devices: Case series.
Catheter Cardiovasc Interv. 2023;101:1235-1238.
PubMed Abstract available

May 2023

WOLFRUM M, Moccetti F, Loretz L, Bossard M, et al
Cerebral embolic protection during transcatheter aortic valve replacement: Insights from a consecutive series with the Sentinel cerebral protection device.
Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30697.
PubMed Abstract available

DE FILIPPO O, Bruno F, Pinxterhuis TH, Gasior M, et al
Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30696.
PubMed Abstract available

DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
Postprocedural trans-mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair.
Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30698.
PubMed Abstract available

RJOOB K, McGilligan V, McAllister R, Bond R, et al
What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity.
Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30684.
PubMed Abstract available

HO CB, Vejlstrup NG, De Backer O, Sondergaard L, et al
Intracardiac echocardiogram to diagnose infective endocarditis after transcatheter aortic valve-in-valve implantation.
Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30694.
PubMed Abstract available

OKSNES A, Skaar E, Engan B, Bleie O, et al
Effectiveness, safety, and patient reported outcomes of a planned investment procedure in higher-risk chronic total occlusion percutaneous coronary intervention: Rationale and design of the invest-CTO study.
Catheter Cardiovasc Interv. 2023 May 17. doi: 10.1002/ccd.30692.
PubMed Abstract available

SPARGIAS K, Lim DS, Makkar R, Kar S, et al
Three-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study.
Catheter Cardiovasc Interv. 2023 May 13. doi: 10.1002/ccd.30686.
PubMed Abstract available

DING D, Tu S, Li Y, Li C, et al
Quantitative flow ratio modulated by intracoronary optical coherence tomography for predicting physiological efficacy of percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30681.
PubMed Abstract available

GHETTI G, Bendandi F, Donati F, Ciurlanti L, et al
Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30688.
PubMed Abstract available

KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
Aortocoronary dissection during percutaneous coronary interventions for chronic total occlusion: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30680.
PubMed Abstract available

HAMEED I, Ahmed A, Kumar A, Li E, et al
Mild aortic insufficiency following transcatheter aortic valve replacement: A systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30674.
PubMed Abstract available

ZHANG YJ, Ma WR, Xu B, Huang ZH, et al
Retrograde percutaneous coronary intervention of chronic total occlusion via discontinuous septal channels.
Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30678.
PubMed Abstract available

CALI F, Pagnesi M, Pezzola E, Montisci A, et al
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review.
Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30682.
PubMed Abstract available

CADER A, Alasnag M
Is there a woman paradox? Commentary on the Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
Catheter Cardiovasc Interv. 2023 May 8. doi: 10.1002/ccd.30672.
PubMed

BUCKLEY AJ, Hensey M, O'Connor S, Maree A, et al
Dental screening prior to transcatheter versus surgical aortic valve replacement: International Survey of Current Practices.
Catheter Cardiovasc Interv. 2023 May 7. doi: 10.1002/ccd.30675.
PubMed

MUSTAFA U, Helmy T
TAVR for all-Is it time?
Catheter Cardiovasc Interv. 2023;101:1174-1175.
PubMed

FELDMAN D, Cao D, Sartori S, Zhang Z, et al
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv. 2023;101:1134-1143.
PubMed Abstract available

SAMIMI S, Chavez Ponce A, Alarouri HS, Shaer AE, et al
Predictors of hemodynamic response to mitral transcatheter edge-to-edge repair.
Catheter Cardiovasc Interv. 2023;101:1120-1127.
PubMed Abstract available

MASSUSSI M, Adamo M, Rosati F, Chizzola G, et al
Coronary artery disease and TAVI: Current evidence on a recurrent issue.
Catheter Cardiovasc Interv. 2023;101:1154-1160.
PubMed Abstract available

YIN J, Wang R, Chen H, Lu H, et al
In vivo evaluation of intravascular lithotripsy in a healthy porcine coronary model.
Catheter Cardiovasc Interv. 2023;101:1062-1070.
PubMed Abstract available

SETO AH
Cut, score, press, shock, or ablate?
Catheter Cardiovasc Interv. 2023;101:975-977.
PubMed

April 2023

YESANTHARAO PS, Etchill EW, Zhou AL, Ong CS, et al
The impact of a statewide payment reform on transcatheter aortic valve replacement (TAVR) utilization and readmissions.
Catheter Cardiovasc Interv. 2023 Apr 27. doi: 10.1002/ccd.30670.
PubMed Abstract available

SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
Computed tomography-derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta-analysis of observational studies.
Catheter Cardiovasc Interv. 2023 Apr 18. doi: 10.1002/ccd.30666.
PubMed Abstract available

HOSSEINI M, Lahr BD, Greason KL, Arghami A, et al
Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion.
Catheter Cardiovasc Interv. 2023 Apr 10. doi: 10.1002/ccd.30658.
PubMed Abstract available

HANNAN EL, Zhong Y, Cozzens K, Osinaga A, et al
Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York.
Catheter Cardiovasc Interv. 2023 Apr 1. doi: 10.1002/ccd.30648.
PubMed Abstract available

GRINES CL, Tummala PE
Calcified coronary nodule: Tip of the iceberg on a road full of thorns.
Catheter Cardiovasc Interv. 2023;101:959-960.
PubMed

HADDAD RN, Dautry R, Bonnet D, Malekzadeh-Milani S, et al
Transvenous retrograde thoracic duct embolization for effective treatment of recurrent plastic bronchitis after fontan palliation.
Catheter Cardiovasc Interv. 2023;101:863-869.
PubMed Abstract available

March 2023

TORABI AJ, Von der Lohe E, Kovacs RJ, Frick KA, et al
Measures of social deprivation and outcomes after percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30642.
PubMed Abstract available

MEIJERINK F, Holierook M, Eberl S, Robbers-Visser D, et al
Dobutamine stress echocardiography during transcatheter edge-to-edge mitral valve repair predicts residual mitral regurgitation.
Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30645.
PubMed Abstract available

SIMSEK B, Khatri J, Young L, Kostantinis S, et al
Same day discharge versus overnight observation following chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv. 2023 Mar 24. doi: 10.1002/ccd.30644.
PubMed Abstract available

MORI H, Kurita T, Takasaki A, Dohi K, et al
Plaque characterization of a saphenous vein graft by near-infrared spectroscopy and histopathology in a patient with a percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30641.
PubMed Abstract available

HILLEGASS WB
Vascular closure after transfemoral transcatheter aortic valve replacement: Further randomized trials are justified.
Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30640.
PubMed

RYAN N, Alasnag M
Commentary on "Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry".
Catheter Cardiovasc Interv. 2023 Mar 21. doi: 10.1002/ccd.30643.
PubMed

ALLANA SS, Brilakis ES
What is the role of drug-coated balloons in chronic total occlusion percutaneous coronary intervention?
Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30632.
PubMed

ALI N, Hildick-Smith D, Parker J, Malkin CJ, et al
Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry.
Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30627.
PubMed Abstract available

AVRAN A, Zuffi A, Gobbi C, Gasperetti A, et al
Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30616.
PubMed Abstract available

POSTALIAN A, Krajcer Z
The relationship between chronic kidney disease and "complex" percutaneous coronary intervention: Uncovering the details.
Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30612.
PubMed

LEE A, Gilchrist IC
A tale of two registries: Trends and outcomes of percutaneous coronary intervention in two transatlantic populations.
Catheter Cardiovasc Interv. 2023 Mar 2. doi: 10.1002/ccd.30608.
PubMed

UEYAMA H, Block PC
Can patients be selected for transcatheter edge-to-edge repair based on the baseline transmitral gradient?
Catheter Cardiovasc Interv. 2023;101:830-831.
PubMed

HEUSER RR
Regulators can we get DCB balloons approved for use in the United States?
Catheter Cardiovasc Interv. 2023;101:834-835.
PubMed

MANGIERI A, Nerla R, Castriota F, Reimers B, et al
Cutting balloon to optimize predilation for stent implantation: The COPS randomized trial.
Catheter Cardiovasc Interv. 2023;101:798-805.
PubMed Abstract available

February 2023

UENO K, Morita N, Kojima Y, Takahashi H, et al
Serial quantitative angiographic study of target lumen enlargement after drug-coated balloon angioplasty for native coronary artery disease.
Catheter Cardiovasc Interv. 2023 Feb 25. doi: 10.1002/ccd.30598.
PubMed Abstract available

IGLESIAS JF, Muller O, Losdat S, Roffi M, et al
Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized t
Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30600.
PubMed Abstract available

HEATON J, Singh S, Nanavaty D, Okoh AK, et al
Impact of frailty on outcomes in acute ST-elevated myocardial infarctions undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30595.
PubMed Abstract available

WILL M, Schwarz K, Weiss T, Leibundgut G, et al
The impact of chronic total occlusions in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30601.
PubMed Abstract available

SEDHOM R, Dang AT, Elwagdy A, Megaly M, et al
Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30597.
PubMed Abstract available

REMPAKOS A, Simsek B, Kostantinis S, Karacsonyi J, et al
Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30581.
PubMed Abstract available

KOSTANTINIS S, Simsek B, Karacsonyi J, Rempakos A, et al
Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry.
Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30580.
PubMed Abstract available

NATANZON SS, Koseki K, Kaewkes D, Koren O, et al
Society of thoracic surgeons risk score and left atrial pressure for predicting clinical outcomes among transcatheter mitral edge-to-edge repair patients.
Catheter Cardiovasc Interv. 2023;101:596-604.
PubMed Abstract available

ARUNOTHAYARAJ S, Lassen JF, Clesham GJ, Spence MS, et al
Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial.
Catheter Cardiovasc Interv. 2023;101:553-562.
PubMed Abstract available

ERDEM S, An SY, McAlister CA, Basra SS, et al
Suicide left ventricle following protamine: A case report.
Catheter Cardiovasc Interv. 2023;101:592-595.
PubMed Abstract available

January 2023

LUGO-FAGUNDO N, Pierre K, Adedinsewo D, Simard T, et al
The impact of baseline transmitral diastolic mean gradient on left atrial pressure reduction in patients undergoing transcatheter mitral valve edge-to-edge repair.
Catheter Cardiovasc Interv. 2023 Jan 30. doi: 10.1002/ccd.30577.
PubMed Abstract available

ALVAREZ-COVARRUBIAS HA, Joner M, Cassese S, Warmbrunn M, et al
Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease.
Catheter Cardiovasc Interv. 2023 Jan 29. doi: 10.1002/ccd.30576.
PubMed Abstract available

HIRUMA T, Higuchi R, Saji M, Takamisawa I, et al
Transcatheter aortic valve replacement-related aortic dissection: A clinical case series.
Catheter Cardiovasc Interv. 2023 Jan 26. doi: 10.1002/ccd.30574.
PubMed Abstract available

KARACSONYI J, Alaswad K, Krestyaninov O, Karmpaliotis D, et al
Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO Registry.
Catheter Cardiovasc Interv. 2023 Jan 25. doi: 10.1002/ccd.30564.
PubMed Abstract available

KAWAMURA Y, Yoshimachi F, Kasai S, Ikari Y, et al
Novel dual guiding catheter technique for kissing balloon inflation in percutaneous coronary intervention for bifurcated chronic total occlusive lesion.
Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30568.
PubMed Abstract available

CHEN H, Spirito A, Sartori S, Nicolas J, et al
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30569.
PubMed Abstract available

RASANEN A, Karkkainen JM, Eranti A, Eranen J, et al
Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept.
Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30558.
PubMed Abstract available

AZZALINI L, Boudou N, Avran A, Kane J, et al
Role of the retrograde Carlino technique for chronic total occlusion percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30565.
PubMed Abstract available

SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
Cusp-overlap versus coplanar view in transcatheter aortic valve implantation with self-expandable valves: A meta-analysis of comparative studies.
Catheter Cardiovasc Interv. 2023 Jan 19. doi: 10.1002/ccd.30562.
PubMed Abstract available

MONTARELLO NJ, Quagliana A, Sondergaard L, De Backer O, et al
Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve.
Catheter Cardiovasc Interv. 2023 Jan 18. doi: 10.1002/ccd.30561.
PubMed Abstract available

SAVVOULIDIS P, Nadir AM, Mechery A, Doshi SN, et al
A very rare vascular complication of the Edwards expandable eSheath during transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2023 Jan 14. doi: 10.1002/ccd.30557.
PubMed Abstract available

ISMAYL M, Machanahalli Balakrishna A, Elgayesh MM, Thandra A, et al
Impact of sex on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter mitral valve replacement (TMVR): Analysis from the nationwide readmission database.
Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30549.
PubMed Abstract available

CHEN J, Yang Y, Song W, Feng D, et al
Transcatheter tricuspid valve-in-valve implantation for degenerated surgical bioprosthesis.
Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30554.
PubMed Abstract available

DAVIS MG, Blankenship JC
PCI for late STEMI: Better late than never?
Catheter Cardiovasc Interv. 2023;101:11-12.
PubMed

DOOST A, Chilmeran A, Gomes A, Dworakowski R, et al
Single arterial access closure of post-infarction ventricular septal defect: A case series.
Catheter Cardiovasc Interv. 2023;101:209-216.
PubMed Abstract available

SHIBBANI K, Aboulhosn J, Levi D, Mohammad Nijres B, et al
Hybrid approach for harmony transcatheter pulmonary valve replacement.
Catheter Cardiovasc Interv. 2023;101:135-139.
PubMed Abstract available

BINGEN BO, Al Amri I, Montero-Cabezas JM, van der Kley F, et al
Bail out lithotripsy to treat delayed valve-in-valve TAVR-related coronary obstruction.
Catheter Cardiovasc Interv. 2023;101:97-101.
PubMed Abstract available

December 2022

BARBOSA MOREIRA MJ, Peixoto NADA, Udoma-Udofa OC, de Araujo SLS, et al
Direct oral anticoagulant versus antiplatelet therapy following transcatheter aortic valve replacement in patients without prior or concurrent indication for anticoagulation: A meta-analysis of randomized studies.
Catheter Cardiovasc Interv. 2022 Dec 27. doi: 10.1002/ccd.30532.
PubMed Abstract available

ISOGAI T, Agrawal A, Shekhar S, Spilias N, et al
One-year clinical and echocardiographic outcomes of transcatheter aortic valve replacement with SAPIEN 3 Ultra versus SAPIEN 3.
Catheter Cardiovasc Interv. 2022 Dec 13. doi: 10.1002/ccd.30515.
PubMed Abstract available

ROUT A, Sharma A, Ikram S, Garg A, et al
Short-term dual antiplatelet therapy for 1-3 months after percutaneous coronary intervention using drug eluting stents: A systematic review and meta-analysis of randomized clinical trials.
Catheter Cardiovasc Interv. 2022 Dec 9. doi: 10.1002/ccd.30521.
PubMed Abstract available

QIAN J, Wu Y, Li C, Yin J, et al
Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
Catheter Cardiovasc Interv. 2022 Dec 8. doi: 10.1002/ccd.30472.
PubMed Abstract available

ZAID S, Haniyeh AA, Rosenzveig A, Malik A, et al
Minimalist transcatheter aortic valve replacement misses paravalvular regurgitation: Incidence and echocardiographic distribution of missed paravalvular regurgitation.
Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30512.
PubMed Abstract available

OGAMI T, Kliner DE, Toma C, Serna-Gallegos D, et al
Readmission with infective endocarditis within 90 days following transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30508.
PubMed Abstract available

EL HAJJ M, Krajcer Z
Percutaneous tricuspid valve repair: A safer alternative to traditional approaches?
Catheter Cardiovasc Interv. 2022;100:1300-1301.
PubMed

MICHAIL M, Cockburn J, Tanseco KVP, Arunothayaraj S, et al
Feasibility of transcaval access TAVI in morbidly obese patients: A single-center experience.
Catheter Cardiovasc Interv. 2022;100:1302-1306.
PubMed Abstract available

TOMII D, Okuno T, Lanz J, Stortecky S, et al
Aortic annulus ellipticity and outcomes after transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2022 Dec 1. doi: 10.1002/ccd.30507.
PubMed Abstract available

November 2022

TANNER R, Murphy S, Malone C, McGorrian C, et al
Correlation of aortic valve annular plane assessment by on-table three-dimensional rotational angiography and preprocedural computed tomography.
Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30469.
PubMed Abstract available

NG JCK, Ang H, Zhong L, Hakim D, et al
Multimodality imaging results of TAP versus novel modified TAP stenting in coronary bifurcation: From bench testing to first-in-man investigation.
Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30496.
PubMed Abstract available

AZZALINI L, Moroni F, Dawson KL, Kearney KE, et al
Chronic total occlusion percutaneous coronary intervention in heart transplant patients.
Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30476.
PubMed Abstract available

SAMMOUR YM, Lak H, Chahine J, Abushouk A, et al
Clinical and echocardiographic outcomes with new-onset left bundle branch block after SAPIEN-3 transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30488.
PubMed Abstract available

BALDUS S, Schofer N, Hausleiter J, Friedrichs K, et al
Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results.
Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30450.
PubMed Abstract available

NAGRAJ S, Tzoumas A, Kakargias F, Giannopoulos S, et al
Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta-analysis of 14 studies comprising 4226 patients.
Catheter Cardiovasc Interv. 2022 Nov 6. doi: 10.1002/ccd.30446.
PubMed Abstract available

SELVARAJ V, Chatterjee S, Hirai T, Abbott JD, et al
Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Catheter Cardiovasc Interv. 2022 Nov 3. doi: 10.1002/ccd.30467.
PubMed Abstract available

LEE HJ, Mejia-Renteria H, Escaned J, Doh JH, et al
Prediction of functional results of percutaneous coronary interventions with virtual stenting and quantitative flow ratio.
Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30451.
PubMed Abstract available

MEREDITH T, Scheuer S, Hoffman M, Joshi Y, et al
Coronary angiography of the ex-situ beating donor heart in a portable organ care system.
Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30455.
PubMed Abstract available

MILLER MS, Cutts J, Donatelle M, Shah K, et al
Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair.
Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30471.
PubMed Abstract available

ABDULLA A, Jneid H
Transcatheter therapies for severe aortic and mitral stenosis: To stage or not to stage?
Catheter Cardiovasc Interv. 2022;100:901-902.
PubMed

ALLANA SS, Brilakis ES
How good is intravascular brachytherapy for treating in-stent restenosis?
Catheter Cardiovasc Interv. 2022;100:763-764.
PubMed

NARAYANAN A, Jneid H
A new frontier in left atrial appendage closure.
Catheter Cardiovasc Interv. 2022;100:929-930.
PubMed

UEYAMA H, Block PC
Membranous septum length may not be the answer.
Catheter Cardiovasc Interv. 2022;100:877-878.
PubMed

JONES EL, Blankenship JC
Women deserve the best care.
Catheter Cardiovasc Interv. 2022;100:936-937.
PubMed

SATLER LF
When possible, try to avoid emergent transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022;100:839-840.
PubMed

TAYLOR A, Yang J, Dubin A, Chubb MH, et al
Ventricular arrhythmias following transcatheter pulmonary valve replacement with the harmony TPV25 device.
Catheter Cardiovasc Interv. 2022;100:766-773.
PubMed Abstract available

CHAVARRIA J, Falcao F, Dutra G, Sathananthan J, et al
Bespoke valve sizing avoids annular rupture in patients treated with a balloon-expandable transcatheter heart valve.
Catheter Cardiovasc Interv. 2022;100:823-831.
PubMed Abstract available

SIMSEK B, Kostantinis S, Karacsonyi J, Allana S, et al
Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS-BIFURCATION registry.
Catheter Cardiovasc Interv. 2022;100:749-755.
PubMed Abstract available

CHAMI T, Mahowald MK, Brilakis E
Retrograde approach for rewiring a jailed side branch during double kissing crush stenting.
Catheter Cardiovasc Interv. 2022;100:756-758.
PubMed Abstract available

SHAMEKHI J, Hasse C, Veulemans V, Al-Kassou B, et al
A simplified cardiac damage staging predicts the outcome of patients undergoing TAVR-A multicenter analysis.
Catheter Cardiovasc Interv. 2022;100:850-859.
PubMed Abstract available

WINSCOTT JG, Hillegass WB
Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure.
Catheter Cardiovasc Interv. 2022;100:747-748.
PubMed

UEYAMA H, Block PC
Data are data: Do we need a randomized trial of transcatheter aortic valve replacement for bicuspid valves?
Catheter Cardiovasc Interv. 2022;100:1132-1133.
PubMed

SALAETS T, Cools B, De Meester P, Heying R, et al
Stent expansion of restrictive Fontan conduits to nominal diameter and beyond.
Catheter Cardiovasc Interv. 2022;100:1059-1066.
PubMed Abstract available

NAGASAKA T, Amanai S, Ishibashi Y, Aihara K, et al
Long-term outcomes of intermediate coronary stenosis in patients undergoing hemodialysis after deferred revascularization based on fractional flow reserve.
Catheter Cardiovasc Interv. 2022;100:971-978.
PubMed Abstract available

ALLALI A, Toelg R, Abdel-Wahab M, Hemetsberger R, et al
Combined rotational atherectomy and cutting balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions: The PREPARE-CALC-COMBO study.
Catheter Cardiovasc Interv. 2022;100:979-989.
PubMed Abstract available

PICCOLO R, Esposito G
Peripheral arterial disease and multisite atherosclerosis in patients undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2022;100:1146-1147.
PubMed

SETH A, Ezhumalai B
Percutaneous Coronary Intervention of bifurcation lesions: The proof is in the pudding!
Catheter Cardiovasc Interv. 2022;100:1148-1149.
PubMed

ALLANA SS, Brilakis ES
Why complex and high risk percutaneous coronary interventions should be offered to selected octogenarians/nonagenarians.
Catheter Cardiovasc Interv. 2022;100:1143-1145.
PubMed

BUCCOLA J, Meinen J, Spinelli J, Hammerstone M, et al
Investigating real-world impact of optical coherence tomography workflow-guided coronary interventions: Design and rationale of the LightLab Clinical Initiative.
Catheter Cardiovasc Interv. 2022;100 Suppl 1:S1-S6.
PubMed Abstract available

SHLOFMITZ E, Croce K, Bezerra H, Sheth T, et al
The MLD MAX OCT algorithm: An imaging-based workflow for percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2022;100 Suppl 1:S7-S13.
PubMed Abstract available

KHUDDUS MA, Darki A, Padaliya BB, West NEJ, et al
Improving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow.
Catheter Cardiovasc Interv. 2022;100 Suppl 1:S14-S24.
PubMed Abstract available

October 2022

NAIMI I, Morray B, Portman MA, Steinberg ZL, et al
Use of the PK Papyrus covered coronary stent in the treatment of Kawasaki disease-associated giant coronary artery aneurysms.
Catheter Cardiovasc Interv. 2022 Oct 26. doi: 10.1002/ccd.30458.
PubMed Abstract available

KOSTANTINIS S, Simsek B, Karacsonyi J, Alaswad K, et al
Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv. 2022 Oct 25. doi: 10.1002/ccd.30425.
PubMed Abstract available

TEBAR MARQUEZ D, Moreno R, Galeote G, Jurado-Roman A, et al
Transcatheter aortic valve with a novel self-expandable device in patients with previous mechanical mitral valve prosthesis.
Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30449.
PubMed Abstract available

GERCEK M, Irimie AA, Gercek M, Fox H, et al
Cognitive function in late-stage HFpEF patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention.
Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30443.
PubMed Abstract available

YASHIGE M, Zen K, Takamatsu K, Matoba S, et al
Additional balloon aortic valvuloplasty to overcome the difficult removal of a self-expandable transcatheter aortic valve system due to valve infolding.
Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30444.
PubMed Abstract available

SIDDIQI TJ, Khan MS, Karimi Galougahi K, Shlofmitz E, et al
Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2022 Oct 17. doi: 10.1002/ccd.30416.
PubMed Abstract available

VERREAULT-JULIEN L, Shekiladze N, Wollmuth J, Rinfret S, et al
Single-access for Impella-supported percutaneous coronary intervention using a sheathless technique with an 8 Fr guide.
Catheter Cardiovasc Interv. 2022 Oct 13. doi: 10.1002/ccd.30427.
PubMed Abstract available

Erratum to "Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience".
Catheter Cardiovasc Interv. 2022 Oct 4. doi: 10.1002/ccd.30409.
PubMed

MATHEWS SJ, Brown CL, Kolski BC, Marques VM, et al
Initial experience with a continuous mechanical aspiration system for thrombus removal before percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30389.
PubMed Abstract available

EARLE W, Abdallah G, Meagher S, Shen K, et al
Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital-wide quality improvement initiative.
Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30412.
PubMed Abstract available

ULLAH W, Zahid S, Muhammadzai H, Khalil F, et al
Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database.
Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30407.
PubMed Abstract available

KHOKHAR AA, Giannini F, Zlahoda-Huzior A, Mikhail G, et al
Coronary access after ACURATE neo2 implantation for valve-in-valve TAVR: Insights from ex vivo simulations.
Catheter Cardiovasc Interv. 2022;100:662-666.
PubMed

ZABLAH JE, Dohlen G, Ystgaard MB, Morgan GJ, et al
Piggyback mounting for stent and valve deployment during percutaneous pulmonary valve implantation.
Catheter Cardiovasc Interv. 2022;100:606-611.
PubMed Abstract available

CHAMBERS JW, Martinsen BJ, Sturm RC, Mandair D, et al
Orbital atherectomy of calcified coronary ostial lesions.
Catheter Cardiovasc Interv. 2022;100:553-559.
PubMed Abstract available

September 2022

MEGALY M, Buda K, Karacsonyi J, Kostantinis S, et al
Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2022 Sep 28. doi: 10.1002/ccd.30403.
PubMed Abstract available

BASHAR H, Matetic A, Curzen N, Mamas MA, et al
Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2022 Sep 21. doi: 10.1002/ccd.30404.
PubMed Abstract available

BERKOVITCH A, Segev A, Guetta V, Finkelstein A, et al
Procedural and long-term outcome among patients undergoing expedited trans-catheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30386.
PubMed Abstract available

ABUSHOUK AI, Abdelfattah O, Gad MM, Saad A, et al
Two-year outcomes after transcatheter aortic valve-in-valve implantation in degenerated surgical valves.
Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30388.
PubMed Abstract available

CARANDE EJ, Protty MB, Verhemel S, Hussein MH, et al
Predictors of 30-day and 12-month mortality in left main stem percutaneous coronary intervention 2016-2020: A study from two UK centers.
Catheter Cardiovasc Interv. 2022 Sep 14. doi: 10.1002/ccd.30400.
PubMed Abstract available

ZAHR F, Chadderdon S, Song H, Sako E, et al
Contemporary diagnosis and management of severe tricuspid regurgitation.
Catheter Cardiovasc Interv. 2022 Sep 10. doi: 10.1002/ccd.30364.
PubMed Abstract available

HIOKI H, Watanabe Y, Kozuma K, Ryuzaki T, et al
Validation of reliability and predictivity of membrane septum length measurements for pacemaker need after transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30377.
PubMed Abstract available

AL-FARRA H, Ravelli ACJ, Henriques JPS, Houterman S, et al
Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI-NHR risk model.
Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30398.
PubMed Abstract available

SHAMKHANI W, Rashid M, Mamas M
Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.
Catheter Cardiovasc Interv. 2022 Sep 2. doi: 10.1002/ccd.30366.
PubMed Abstract available

GRINES CL, Dupont A
Turndown for coronary artery bypass surgery: Never say never to revascularization.
Catheter Cardiovasc Interv. 2022;100:367-368.
PubMed Abstract available

TARANTINI G, Cardaioli F
SAPIEN 3 transcatheter heart valve in patients with borderline annulus: "stretched better than bigger?"
Catheter Cardiovasc Interv. 2022;100:422-423.
PubMed

ZAHID S, Khan MZ, Ullah W, Tanveer Ud Din M, et al
In-hospital outcomes of TAVR patients with a bundle branch block: Insights from the National Inpatient Sample 2011-2018.
Catheter Cardiovasc Interv. 2022;100:424-436.
PubMed Abstract available

August 2022

SAGER R, Keller LS, Stehli J, Jakob P, et al
Association of N-terminal pro-B-type natriuretic peptide with mortality in elderly (>/=80 years) patients undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30365.
PubMed Abstract available

MAURINA M, Condello F, Mangieri A, Sanz-Sanchez J, et al
Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications.
Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30385.
PubMed Abstract available

OKUNO T, Dangas GD, Hengstenberg C, Sartori S, et al
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.
Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30370.
PubMed Abstract available

SADAT N, Bruhn D, Scharfschwerdt M, Schaller T, et al
Impact of high-pressure balloon aortic valvuloplasty on the hydrodynamic result after a transcatheter valve-in-valve procedure.
Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30359.
PubMed Abstract available

ZAJARIAS A, Kodali S, McCabe JM, Eng MH, et al
Real-world experience with concomitant or staged transcatheter aortic and mitral valve replacements using balloon-expandable valves.
Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30331.
PubMed Abstract available

SAVAGE ML, Hay K, Murdoch DJ, Walters DL, et al
Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction.
Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30357.
PubMed Abstract available

LIU JD, Zhang SY, Wu YQ, Gong R, et al
Valve implantation for successful sealing of a balloon predilatation-induced annular rupture during transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022 Aug 3. doi: 10.1002/ccd.30353.
PubMed Abstract available

ISOGAI T, Vanguru HR, Krishnaswamy A, Agrawal A, et al
Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30340.
PubMed Abstract available

KOSTANTINIS S, Simsek B, Karacsonyi J, Davies RE, et al
Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30354.
PubMed Abstract available

ENG MH, Zahr F
When should early discharge post-transcatheter aortic valve replacement be blocked?
Catheter Cardiovasc Interv. 2022;100:254-255.
PubMed

VETROVEC GW
Robotic coronary angiography: Advantages of stepping back.
Catheter Cardiovasc Interv. 2022;100:214-215.
PubMed

TARANTINI G, Cardaioli F
Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient.
Catheter Cardiovasc Interv. 2022;100:243-244.
PubMed

HELMY T, Mina G
Single access TAVR. How "minimalist" do we need to be?
Catheter Cardiovasc Interv. 2022;100:233-234.
PubMed

July 2022

SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
Antegrade dissection and re-entry versus parallel wiring in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30346.
PubMed Abstract available

GALLITTO E, Palmerini T, Saia F, Gargiulo M, et al
Iliac "paving & cracking" technique for transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30344.
PubMed Abstract available

SIMSEK B, Gorgulu S, Kostantinis S, Karacsonyi J, et al
Radial access for chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30347.
PubMed Abstract available

DAUTZENBERG L, van Aarle TTM, Stella PR, Emmelot-Vonk M, et al
The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study.
Catheter Cardiovasc Interv. 2022 Jul 13. doi: 10.1002/ccd.30320.
PubMed Abstract available

GALASSI AR, Vadala G, Testa G, Puglisi S, et al
Dual guidewire balloon antegrade fenestration and re-entry technique for coronary chronic total occlusions percutaneous coronary interventions.
Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30324.
PubMed Abstract available

RUSSO M, Chen C, Sethi A, Hakeem A, et al
TAVR in an XXXL annulus (1057 mm(2) ) with type I bicuspid aortic valve.
Catheter Cardiovasc Interv. 2022 Jul 6. doi: 10.1002/ccd.30325.
PubMed Abstract available

FARAG M, Al-Atta A, Abdalazeem I, Salim T, et al
Clinical outcomes of percutaneous coronary intervention in high-risk patients turned down for surgical revascularization.
Catheter Cardiovasc Interv. 2022 Jul 1. doi: 10.1002/ccd.30318.
PubMed Abstract available

ALASNAG M
Lifetime management when a redo is in the balance: Valve-in-valve transcatheter aortic valve replacement or resurgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
Catheter Cardiovasc Interv. 2022;100:131-132.
PubMed

GRINES CL, Marshall JJ
Directional coronary atherectomy revisited.
Catheter Cardiovasc Interv. 2022;100:59-60.
PubMed

LIANG B, Gu N
High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
Catheter Cardiovasc Interv. 2022;100:61-71.
PubMed Abstract available

ASHLEY KE, Hillegass WB
Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
Catheter Cardiovasc Interv. 2022;100:83-84.
PubMed

June 2022

RASHID M, Kinnaird T, Ludman P, Keeble TR, et al
Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.
Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30316.
PubMed Abstract available

ELZANATY AM, Maraey A, Elbadawi A, Khalil M, et al
Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation.
Catheter Cardiovasc Interv. 2022 Jun 27. doi: 10.1002/ccd.30299.
PubMed Abstract available

MEDRANDA GA, Rogers T, Fuery M, Case BC, et al
Impact of left ventricular outflow tract calcium on valve geometry in self-expanding transcatheter aortic-valve replacement.
Catheter Cardiovasc Interv. 2022 Jun 20. doi: 10.1002/ccd.30301.
PubMed Abstract available

PAVANI M, Cerrato E, Franze A, Colombo F, et al
Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
PubMed Abstract available

ARONEY NP, Patterson T, Kalogeropoulos A, Allen CJ, et al
Clinical outcomes following single access transfemoral transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30246.
PubMed Abstract available

ROBERT P, Akodad M, Lattuca B, Gandet T, et al
Transcatheter aortic valve implantation in patients with uninterrupted vitamin K antagonists.
Catheter Cardiovasc Interv. 2022 Jun 5. doi: 10.1002/ccd.30248.
PubMed Abstract available

KOBAYASHI N, Ito Y, Kishi K, Muramatsu T, et al
Procedural results and in-hospital outcomes of percutaneous coronary intervention for chronic total occlusion in patients with reduced left ventricular ejection fraction: Sub-analysis of the Japanese CTO-PCI Expert Registry.
Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30231.
PubMed Abstract available

TARANTINI G, Fraccaro C
Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients-Patients' vulnerability still matters.
Catheter Cardiovasc Interv. 2022;99:2111-2112.
PubMed

KARACSONYI J, Brilakis ES, Chandwaney RH
Guide-Extension Carlino: A novel technique for crossing a microcatheter uncrossable proximal cap during chronic total occlusion interventions.
Catheter Cardiovasc Interv. 2022;99:2038-2042.
PubMed Abstract available

May 2022

DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
Clinical outcomes and predictors in patients with previous cardiac surgery undergoing mitral valve transcatheter edge-to-edge repair.
Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30245.
PubMed Abstract available

KLEIN LW, Anderson HV, Cigarroa J
Integrating shared decision-making in coronary revascularization with quality assurance programs.
Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30222.
PubMed

SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.
Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30228.
PubMed Abstract available

ALACHKAR MN, Muller T, Alnaimi A, Milzi A, et al
Safety and efficacy of transcatheter mitral valve repair in patients with COPD; results from real-world cohort.
Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30238.
PubMed Abstract available

NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
Overview of in-hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
Catheter Cardiovasc Interv. 2022 May 20. doi: 10.1002/ccd.30233.
PubMed Abstract available

VAN HATTEM VAE, Otterspoor LC, Lipsic E, Vlaar PJJ, et al
Right ventricular hematoma: A rare but potentially fatal complication of percutaneous coronary artery intervention.
Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30226.
PubMed Abstract available

CORCIONE N, Berni A, Ferraro P, Morello A, et al
Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes.
Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30179.
PubMed Abstract available

SIMARD T, Reddy YNV, Thaden JJ, Padang R, et al
Atrial mitral regurgitation: Characteristics and outcomes of transcatheter mitral valve edge-to-edge repair.
Catheter Cardiovasc Interv. 2022 May 10. doi: 10.1002/ccd.30224.
PubMed Abstract available

ONO M, Onuma Y, Kawashima H, Hara H, et al
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30217.
PubMed Abstract available

JOVIN IS, Warsavage TJ, Plomondon ME, Grunwald GK, et al
Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30218.
PubMed Abstract available

WANG M, Liu H, Xu B, Bian X, et al
Protective ballooning technique for prevention of side branch occlusion in coronary nonleft main true bifurcation lesions: A single-center study.
Catheter Cardiovasc Interv. 2022;99 Suppl 1:1418-1423.
PubMed Abstract available

LEE A, Kimmelstiel C
Stretching and cutting after drilling. Vessel preparation following rotational atherectomy.
Catheter Cardiovasc Interv. 2022;99:1750-1751.
PubMed

POSTALIAN A, Krajcer Z
Mitral annular calcification-A marker of risk, and a harbinger of technical challenges during intervention.
Catheter Cardiovasc Interv. 2022;99:1817-1818.
PubMed

TARANTINI G, Cardaioli F
TAVR and stroke: A common evolution.
Catheter Cardiovasc Interv. 2022;99:1906-1907.
PubMed

PATEL N, Bandyopadhyay D, Agarwal G, Chakraborty S, et al
Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: A meta-analysis.
Catheter Cardiovasc Interv. 2022;99:1741-1749.
PubMed Abstract available

SEDHOM R, Megaly M, Saad M, Elbadawi A, et al
Transcatheter edge-to-edge repair of the tricuspid valve: The US experience.
Catheter Cardiovasc Interv. 2022;99:1859-1866.
PubMed Abstract available

TANG GHL, Hooda A, Zaid S, Chuang MY, et al
Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized versus nominally-sized annuli.
Catheter Cardiovasc Interv. 2022;99:1935-1944.
PubMed Abstract available

BEOHAR N, Stone GW, Martinsen BJ, Parise H, et al
Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.
Catheter Cardiovasc Interv. 2022;99:1752-1757.
PubMed Abstract available

VENTURI G, Scarsini R, Pighi M, Kotronias RA, et al
Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI.
Catheter Cardiovasc Interv. 2022;99:1925-1934.
PubMed Abstract available

MOHANTY BD, Coylewright M, Sequeira AR, Shin D, et al
Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER-2.
Catheter Cardiovasc Interv. 2022;99:1877-1885.
PubMed Abstract available

PORAT A, Gordon M, Perlman G, Planer D, et al
Mass to voltage ratio index predicts mortality following TAVI.
Catheter Cardiovasc Interv. 2022;99:1918-1924.
PubMed Abstract available

ROTTLANDER D, Beucher H, Ghaddioui KA, Boekstegers P, et al
Continuous atrial pressure monitoring via steerable guide catheter in transcatheter mitral and tricuspid edge-to-edge repair.
Catheter Cardiovasc Interv. 2022;99:1796-1806.
PubMed Abstract available

YA'QOUB L, Gad M, Faza NN, Kunkel KJ, et al
Sex differences in outcomes of transcatheter edge-to-edge repair with MitraClip: A meta-analysis.
Catheter Cardiovasc Interv. 2022;99:1819-1828.
PubMed Abstract available

ALADIN AI, Case BC, Wermers JP, Rogers T, et al
Overview of FDA Circulatory System Devices Panel virtual meeting on TriGUARD 3 cerebral embolic protection.
Catheter Cardiovasc Interv. 2022;99:1789-1795.
PubMed Abstract available

April 2022

BRUNO F, Elia E, D'Ascenzo F, Marengo G, et al
Valve-in-valve transcatheter aortic valve replacement or re-surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
Catheter Cardiovasc Interv. 2022 Apr 29. doi: 10.1002/ccd.30219.
PubMed Abstract available

MEMON MM, Siddiqui AA, Amin E, Shaikh FN, et al
Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2022 Apr 27. doi: 10.1002/ccd.30213.
PubMed Abstract available

KAWAGUCHI T, Miyoshi T, Hayashi M, Ishizu K, et al
Efficacy of larger valve sizing with underfilling in balloon-expandable transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30188.
PubMed Abstract available

HOLLOWED J, Akhondi A, Rabbani A, Oncel D, et al
Single versus double Perclose techniques for vascular closure during transfemoral transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30176.
PubMed Abstract available

BALDETTI L, Beneduce A, Boccellino A, Pagnesi M, et al
Bedside intra-aortic balloon pump insertion in cardiac intensive care unit: A single-center experience.
Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30197.
PubMed Abstract available

SALEM H, Mintz GS, Matsumura M, Zhang M, et al
Reasons for lesion uncrossability as assessed by intravascular ultrasound.
Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30202.
PubMed Abstract available

HOU S, Pan W, Zhou D, Ge J, et al
Percutaneous balloon mitral valvuloplasty using veno-arterial loop and neuro-embolic protection for mitral stenosis with thrombus.
Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30203.
PubMed Abstract available

PIRIOU PG, Manigold T, Letocart V, Le Ruz R, et al
Outcomes of emergency transcatheter aortic valve replacement in patients with cardiogenic shock: A multicenter retrospective study.
Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30194.
PubMed Abstract available

YONG CM, Jaluba K, Batchelor W, Gummipundi S, et al
Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex.
Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30182.
PubMed Abstract available

INCI E, Block PC
A little leak goes a long way! 5-Year-outcome after transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2022;99:1590-1591.
PubMed Abstract available

LIU X, Chen Y, Lim DS, Wang J, et al
Transcatheter mitral valve repair in patient with atrial functional mitral regurgitation using novel DragonFly device.
Catheter Cardiovasc Interv. 2022;99:1691-1695.
PubMed Abstract available

SEGAR MW, Krajcer Z
Sex-based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap.
Catheter Cardiovasc Interv. 2022;99:1645-1646.
PubMed

TARANTINI G, Rodino G
Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone.
Catheter Cardiovasc Interv. 2022;99:1609-1610.
PubMed

BRUCE CG, Lederman RJ
Troubleshooting transcaval access: Honoring our commitments.
Catheter Cardiovasc Interv. 2022;99:1700-1701.
PubMed

BANSAL A, Jaber WA, Reed GW, Puri R, et al
Surgical versus medical management of infective endocarditis after TAVR.
Catheter Cardiovasc Interv. 2022;99:1592-1596.
PubMed Abstract available

RUGE H, Burri M, Erlebach M, Lange R, et al
Propensity matched analysis of vascular complications using integrated or expandable sheaths for TAVR.
Catheter Cardiovasc Interv. 2022;99:1611-1618.
PubMed Abstract available

GOLDSWEIG AM, Hermiller JB
Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
Catheter Cardiovasc Interv. 2022;99:1597-1598.
PubMed

March 2022

SIMSEK B, Kostantinis S, Karacsonyi J, Hall A, et al
International percutaneous coronary intervention complication survey.
Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30173.
PubMed Abstract available

ZHU Q, Yuan Z, Xu Y, Chen J, et al
Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study.
Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30147.
PubMed Abstract available

LE RUZ R, Guerin P, Leurent G, Leroux L, et al
Mitral valve-in-valve and valve-in-ring procedures: Midterm outcomes in a French nationwide registry.
Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30161.
PubMed Abstract available

JANUSZEK R, Siudak Z, Malinowski KP, Wanha W, et al
Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: Analysis based on a large national registry.
Catheter Cardiovasc Interv. 2022 Mar 22. doi: 10.1002/ccd.30155.
PubMed Abstract available

ESCHENBACH LK, Erlebach M, Deutsch MA, Ruge H, et al
Stroke after transcatheter aortic valve replacement: A severe complication with low predictability.
Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30143.
PubMed Abstract available

SA MP, Jabagi H, Dokollari A, Awad AK, et al
Early and late outcomes of surgical aortic valve replacement with sutureless and rapid-deployment valves versus transcatheter aortic valve implantation: Meta-analysis with reconstructed time-to-event data of matched studies.
Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30162.
PubMed Abstract available

SANZ-SANCHEZ J, Mashayekhi K, Agostoni P, Egred M, et al
Device entrapment during percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30160.
PubMed Abstract available

ROTTLANDER D, Golabkesh M, Degen H, Ogutcu A, et al
Mitral valve edge-to-edge repair versus indirect mitral valve annuloplasty in atrial functional mitral regurgitation.
Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30157.
PubMed Abstract available

VALLURUPALLI S, Hess E, Plomondon ME, Park K, et al
Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30142.
PubMed Abstract available

MANO TB, Ramos R, Cacela D, Patricio L, et al
Not all pseudoaneurysms are femoral-A transcaval transcatheter aortic valve replacement rare complication.
Catheter Cardiovasc Interv. 2022 Mar 3. doi: 10.1002/ccd.30140.
PubMed Abstract available

WINSCOTT JG, Hillegass WB
Successfully treating the common femoral artery "no go zone" with directional atherectomy plus antirestenotic therapy (DAART).
Catheter Cardiovasc Interv. 2022;99:1317-1318.
PubMed

SPIRITO A, Mehran R
Elderly patients with acute myocardial infarction: Targeted or complete revascularization?
Catheter Cardiovasc Interv. 2022;99:979-980.
PubMed

GILANI S, Jneid H
Reaching the optimal volume-quality balance in transfemoral transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022;99:1186-1187.
PubMed

ENG MH, Fang HK
Forgotten and unforgiving.
Catheter Cardiovasc Interv. 2022;99:1287-1288.
PubMed

SIMPSON TF, Kheiri B, Chadderdon S, Song HK, et al
TAVR operator volumes, trends, and geographic variations amongst Medicare beneficiaries in the United States.
Catheter Cardiovasc Interv. 2022;99:1181-1185.
PubMed Abstract available

FABRY N, Hendrickson MJ, Arora S, Vavalle JP, et al
Five-year trends in cause-specific readmissions and cost burden of mitral transcatheter edge-to-edge repair.
Catheter Cardiovasc Interv. 2022;99:1251-1256.
PubMed Abstract available

MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
Catheter Cardiovasc Interv. 2022;99:1047-1058.
PubMed Abstract available

RANARD LS, Vahl TP, Chung CJ, Sadri S, et al
Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions.
Catheter Cardiovasc Interv. 2022;99:1268-1276.
PubMed Abstract available

BATLIVALA SP, Hagel JA, Hirsch R, Shahanavaz S, et al
Transcatheter pulmonary valve-in-valve implantation within the expandable Inspiris Resilia(R) bioprosthetic valve.
Catheter Cardiovasc Interv. 2022;99:1157-1160.
PubMed Abstract available

KANG SL, Ramroop R, Manojlovich L, Runeckles K, et al
Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation?
Catheter Cardiovasc Interv. 2022;99:1138-1148.
PubMed Abstract available

ABUSHOUK AI, Saad AM, Isogai T, Shekhar S, et al
Long-term outcomes of transcatheter valve-in-valve replacement for failed aortic bioprosthesis: A meta-analysis.
Catheter Cardiovasc Interv. 2022;99:1370-1372.
PubMed

KUMAR A, Huded CP, Kassis N, Martin J, et al
Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
Catheter Cardiovasc Interv. 2022;99:1363-1365.
PubMed

February 2022

ASAMI M, Dobner S, Stortecky S, Heg D, et al
Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2022 Feb 16. doi: 10.1002/ccd.30132.
PubMed Abstract available

ELBADAWI A, Tan BE, Sammour Y, Saad M, et al
Sex-related differences in the trends and outcomes of trans-septal transcatheter mitral valve replacement: Insights from the National Readmissions Database.
Catheter Cardiovasc Interv. 2022 Feb 7. doi: 10.1002/ccd.30072.
PubMed Abstract available

VALVO R, Costa G, Tamburino C, Barbanti M, et al
Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30116.
PubMed Abstract available

BRUNNER S, Wolfrum M, Moccetti F, Stampfli SF, et al
The relevance of tricuspid regurgitation in patients undergoing percutaneous treatment of mitral regurgitation.
Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30114.
PubMed Abstract available

KITE TA, Ladwiniec A, Owens CG, Chase A, et al
Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.
Catheter Cardiovasc Interv. 2022;99:305-313.
PubMed Abstract available

KHAN AA, Dangas G
Is cardiac surgery backup required for left main stenting?
Catheter Cardiovasc Interv. 2022;99:607-608.
PubMed

POSTALIAN A, Krajcer Z
Facilitating future access to the coronary arteries in patients who need transcatheter aortic valve replacement: A significant step in the right direction.
Catheter Cardiovasc Interv. 2022;99:932-933.
PubMed

GOLDSWEIG AM, Baron SJ
Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022;99:904-905.
PubMed Abstract available

UPADHYAY A, Jneid H
Predischarge transthoracic echocardiogram after TAVI - Is it really necessary?
Catheter Cardiovasc Interv. 2022;99:867-868.
PubMed

O'NEILL BP, Wang DD, Caranasos TG, Chitwood WR Jr, et al
Initial in-human experience with the conveyor cardiovascular system for the delivery of large profile transcatheter valve devices.
Catheter Cardiovasc Interv. 2022;99:943-948.
PubMed Abstract available

WELLE GA, El-Sabawi B, Thaden JJ, Greason KL, et al
Effect of eliminating pre-discharge transthoracic echocardiogram on outcomes after TAVR.
Catheter Cardiovasc Interv. 2022;99:861-866.
PubMed Abstract available

MCINERNEY A, Travieso Gonzalez A, Castro Mejia A, Tirado-Conte G, et al
Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve.
Catheter Cardiovasc Interv. 2022;99:723-729.
PubMed Abstract available

G TOTH G, Ono M, Buschmann E, Wu X, et al
Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
Catheter Cardiovasc Interv. 2022;99:424-432.
PubMed Abstract available

January 2022

ZHOU D, Chen J, Fan J, Yidilisi A, et al
Self-expanding transcatheter aortic valve replacement in patients with extremely horizontal aortas.
Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30094.
PubMed Abstract available

TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
PubMed Abstract available

OGAMI T, Kurlansky P, Takayama H, Ning Y, et al
Three-year survival of transcatheter versus surgical aortic valve replacement in dialysis.
Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30045.
PubMed Abstract available

PAULUS MG, Meindl C, Hamerle M, Schach C, et al
Reduction of radiation exposure during transcatheter edge-to-edge mitral valve repair.
Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30046.
PubMed Abstract available

CHEN S, Li J, Qiu M, Ma S, et al
Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30089.
PubMed Abstract available

LI J, Liu X, Ma S, Na K, et al
Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30099.
PubMed Abstract available

YUAN S, He J, Cai Z, Zhang R, et al
Intra-aortic balloon pump in cardiogenic shock: A propensity score matching analysis.
Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30102.
PubMed Abstract available

HONG XL, Li Y, Fu GS, Zhang WB, et al
Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy.
Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30095.
PubMed Abstract available

SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
PubMed Abstract available

LAWLOR MK, Hamid N, Kampaktsis P, Ning Y, et al
Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention.
Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30073.
PubMed Abstract available

KATO N, Pellikka PA, Scott CG, Lee AT, et al
Impact of mitral intervention on outcomes of patients with mitral valve dysfunction and annulus calcification.
Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30093.
PubMed Abstract available

SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
PubMed Abstract available

SCHOECHLIN S, Hein M, Brennemann T, Eichenlaub M, et al
5-Year outcomes after transcatheter aortic valve implantation: Focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters.
Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30083.
PubMed Abstract available

FREIXA X, Estevez-Loureiro R, Pascual I, Carrasco-Chinchilla F, et al
Procedural and clinical outcomes after repeat edge-to-edge transcatheter mitral valve repair.
Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30053.
PubMed Abstract available

PARAGGIO L, Burzotta F, Graziani F, Aurigemma C, et al
Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve.
Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30082.
PubMed Abstract available

LI Y, Li J, Qiu M, Ma S, et al
Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30077.
PubMed Abstract available

ADAMO M, Pagnesi M, Popolo Rubbio A, Branca L, et al
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation.
Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30062.
PubMed Abstract available

CHIOU A, Yap J, Russo S, Stripe BR, et al
Understanding repeat hospitalizations in intermediate-to-high risk aortic stenosis patients following transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30066.
PubMed Abstract available

CAJIGAS HR, Kaptzan T, Lewis B, El-Sabbagh A, et al
The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification.
Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30057.
PubMed Abstract available

MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
PubMed Abstract available

SIMARD T, Lloyd J, Crestanello J, Thaden JJ, et al
Five-year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration.
Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30059.
PubMed Abstract available

SIMSEK B, Brilakis ES
Chronic total occlusion percutaneous coronary intervention in prior coronary artery bypass graft surgery patients: Caveat Emptor!
Catheter Cardiovasc Interv. 2022;99:85-87.
PubMed

OKUYA Y, Moussa ID
Surgical bailout after transcatheter aortic valve replacement: Hospital procedural volume matters!
Catheter Cardiovasc Interv. 2022;99:169-170.
PubMed

BELARDI J, Lamelas P
Serious adverse events related to transcatheter aortic valve replacement are infrequent: FORWARD 3-years.
Catheter Cardiovasc Interv. 2022;99:179-180.
PubMed

UPADHYAY A, Jneid H
Frailty and malnutrition as influential drivers of outcomes after aortic valve replacement.
Catheter Cardiovasc Interv. 2022;99:158-159.
PubMed

RODRIGUEZ OGANDO A, Ballesteros F, Martinez JLZ
Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve.
Catheter Cardiovasc Interv. 2022;99:E38-E42.
PubMed Abstract available

MOVAHED MR
Distal administration of very high doses of adenosine using over-the-wire balloon or export catheter should be the first choice for treatment of patients with resistant no-reflow.
Catheter Cardiovasc Interv. 2022;99:E43.
PubMed

December 2021

GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
PubMed Abstract available

VOGL BJ, Darestani YM, Lilly SM, Thourani VH, et al
Impact of blood pressure on coronary perfusion and valvular hemodynamics after aortic valve replacement.
Catheter Cardiovasc Interv. 2021 Dec 22. doi: 10.1002/ccd.30052.
PubMed Abstract available

HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
PubMed Abstract available

OKOH AK, Chen C, Kassotis J, Soliman F, et al
Utilizing ambulatory electrocardiogram monitoring to reduce conduction related death after transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2021 Dec 1. doi: 10.1002/ccd.30027.
PubMed Abstract available

KORNOWSKI R
Left main coronary revascularization strategies in the COVID-19 era.
Catheter Cardiovasc Interv. 2021;98:1262-1263.
PubMed

KUMAR A, Jneid H
Predicting mortality after percutaneous coronary intervention: The need for improved risk models.
Catheter Cardiovasc Interv. 2021;98:1298-1299.
PubMed

MOUSSA ID
Prediction of left circumflex artery impingement after indirect mitral annuloplasty with the carillon device: "There is more to this than meets the eye!"
Catheter Cardiovasc Interv. 2021;98:1402-1403.
PubMed

SAIA F
Transcatheter edge-to-edge mitral valve repair: Should we stay tied to COAPT tiers?
Catheter Cardiovasc Interv. 2021;98:1413-1414.
PubMed

TOPAZ O
Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations.
Catheter Cardiovasc Interv. 2021;98:1250-1251.
PubMed

SCHNEIDER LM, Nicoleta N, Schepperle N, Paukovitsch M, et al
Implications of concomitant obstructive or restrictive pulmonary diseases on functional and clinical results after MitraClip.
Catheter Cardiovasc Interv. 2021;98:E1000-E1006.
PubMed Abstract available

OJEDA S, Azzalini L, Suarez de Lezo J, Johal GS, et al
Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry.
Catheter Cardiovasc Interv. 2021;98:1241-1249.
PubMed Abstract available

November 2021

BHARDWAJ B, Gunzburger E, Valle JA, Grunwald GK, et al
Radial versus femoral access for left main percutaneous coronary intervention: An analysis from the Veterans Affairs Clinical, Reporting, and Tracking Program.
Catheter Cardiovasc Interv. 2021 Nov 30. doi: 10.1002/ccd.30024.
PubMed Abstract available

WANG DD, O'Neill BP, Caranasos TG, Chitwood WR Jr, et al
Comparative differences of mitral valve-in-valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves.
Catheter Cardiovasc Interv. 2021 Nov 29. doi: 10.1002/ccd.30011.
PubMed Abstract available

HOKKEN TW, de Ronde M, Wolff Q, Schermers T, et al
Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program.
Catheter Cardiovasc Interv. 2021 Nov 27. doi: 10.1002/ccd.30026.
PubMed Abstract available

SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
PubMed Abstract available

GUNARATHNE A, Tan J, Varcoe R, Bhandari S, et al
The impact of learning-curve-experience on transcatheter aortic valve replacement outcomes: Insights from the United Kingdom and Ireland all-comers second-generation ACURATE neo transcatheter aortic heart valve registry.
Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30000.
PubMed Abstract available

DAS TM, Shin J, Czarny MJ, Nanavati J, et al
Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30009.
PubMed Abstract available

KUFNER S, Rai H, Wiebe J, Altevogt F, et al
A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
PubMed Abstract available

NEUSER J, Kempf T, Bauersachs J, Widder JD, et al
Novel self-expanding ALLEGRA transcatheter aortic valve for native aortic stenosis and degenerated bioprosthesis.
Catheter Cardiovasc Interv. 2021 Nov 17. doi: 10.1002/ccd.30003.
PubMed Abstract available

DAVIES RE, Rier JD, McEntegart M, Riley RF, et al
Subintimal tracking and reentry as a tool in CTO-PCI: Past, present, and future.
Catheter Cardiovasc Interv. 2021;98:1144-1151.
PubMed

WOLFRUM M, Moccetti F, Piuhola J, Lehtola H, et al
The Allegra transcatheter heart valve: Short term results from a multicenter registry.
Catheter Cardiovasc Interv. 2021;98:1204-1209.
PubMed Abstract available

ENG MH, Abbas AE, Hahn RT, Lee J, et al
Real world outcomes using 20 mm balloon expandable SAPIEN 3/ultra valves compared to larger valves (23, 26, and 29 mm)-a propensity matched analysis.
Catheter Cardiovasc Interv. 2021;98:1185-1192.
PubMed Abstract available

ORVIN K, Perl L, Landes U, Dvir D, et al
Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry.
Catheter Cardiovasc Interv. 2021;98:E862-E869.
PubMed Abstract available

DE MARCO F, Casenghi M, Spagnolo P, Popolo Rubbio A, et al
A patient-specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique.
Catheter Cardiovasc Interv. 2021;98:E847-E854.
PubMed Abstract available

RAZUK V, Camaj A, Cao D, Nicolas J, et al
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv. 2021;98:E870-E880.
PubMed Abstract available

NAZIR S, Ahuja KR, Ariss RW, Hassanein M, et al
Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure.
Catheter Cardiovasc Interv. 2021;98:E839-E846.
PubMed Abstract available

NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Karacsonyi J, et al
Radial versus femoral access in patients with coronary artery bypass surgery: Frequentist and Bayesian meta-analysis.
Catheter Cardiovasc Interv. 2021 Nov 14. doi: 10.1002/ccd.30010.
PubMed Abstract available

TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
PubMed

LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
PubMed Abstract available

REILLY JP, Parikh PB
Valve-in-valve transcatheter aortic valve replacement versus re-do surgical aortic valve replacement: A call for randomized controlled trials.
Catheter Cardiovasc Interv. 2021;98:948-949.
PubMed

ARSLAN F, Gerckens U
Virtual support for remote proctoring in TAVR during COVID-19.
Catheter Cardiovasc Interv. 2021;98:E733-E736.
PubMed Abstract available

BAGUR R, Jneid H
Coronary artery access after aortic valve intervention.
Catheter Cardiovasc Interv. 2021;98:957-958.
PubMed

KIM JY, Kim SH, Jang SI
Bilateral branch pulmonary artery Pulsta valve implantation for treatment of large right ventricular outflow tract in a high-risk patient.
Catheter Cardiovasc Interv. 2021;98:923-927.
PubMed Abstract available

LE RUZ R, Plessis J, Houeijeh A, Baruteau AE, et al
Edwards SAPIEN XT transcatheter pulmonary valve implantation: 5-year follow-up in a French Registry.
Catheter Cardiovasc Interv. 2021;98:990-999.
PubMed Abstract available

LEE SY, Kim GB, Kim SH, Jang SI, et al
Mid-term outcomes of the Pulsta transcatheter pulmonary valve for the native right ventricular outflow tract.
Catheter Cardiovasc Interv. 2021;98:E724-E732.
PubMed Abstract available

KAPLE RK, Agarwal V, Azarbal A, Sugeng L, et al
Tricuspid clip implantation using the MitraClip system-A step-by-step guide.
Catheter Cardiovasc Interv. 2021;98:1006-1019.
PubMed Abstract available

KHAN AA, Murtaza G, Khalid MF, White CJ, et al
Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2021;98:884-892.
PubMed Abstract available

WIEBE J, Rai H, Kuna C, Cassese S, et al
Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
Catheter Cardiovasc Interv. 2021;98:857-862.
PubMed Abstract available

October 2021

AMIN R, Arunothayaraj S, Kirtchuk D, Williams T, et al
Mobility aids predict mortality after transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2021 Oct 22. doi: 10.1002/ccd.29981.
PubMed Abstract available

SATTAR Y, Abdul Razzack A, Kompella R, Alhajri N, et al
Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: A meta regression-based analysis.
Catheter Cardiovasc Interv. 2021 Oct 20. doi: 10.1002/ccd.29976.
PubMed Abstract available

DAI N, Zhang R, Hu N, Guan C, et al
Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
PubMed Abstract available

STANOVA V, Rieu R, Cote N, Salaun E, et al
In vitro Doppler versus catheter transvalvular pressure gradients in balloon-expandable versus self-expanding transcatheter aortic valves.
Catheter Cardiovasc Interv. 2021 Oct 11. doi: 10.1002/ccd.29974.
PubMed Abstract available

TANG GHL, Sengupta A, Alexis SL, Zaid S, et al
Conventional versus modified delivery system technique in commissural alignment from the Evolut low-risk CT substudy.
Catheter Cardiovasc Interv. 2021 Oct 9. doi: 10.1002/ccd.29973.
PubMed Abstract available

MATSUMOTO S, Ohno Y, Miyamoto J, Ikari Y, et al
Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry.
Catheter Cardiovasc Interv. 2021 Oct 6. doi: 10.1002/ccd.29960.
PubMed Abstract available

MUSUMECI G, Annibali G
Transcarotid access as a first alternative approach to transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2021;98:774-775.
PubMed

OKUYA Y, Moussa ID
Hemolysis after transcatheter mitral valve replacement: An underreported phenomenon!
Catheter Cardiovasc Interv. 2021;98:786-787.
PubMed

HAWAMDEH H, Moliterno DJ
Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
Catheter Cardiovasc Interv. 2021;98:689-690.
PubMed Abstract available

KERN MJ
Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR.
Catheter Cardiovasc Interv. 2021;98:669-670.
PubMed

CHUNG YH, Kim JS, Lee SY, Im E, et al
Safety and usefulness of a novel short track sliding balloon catheter.
Catheter Cardiovasc Interv. 2021;98:E548-E554.
PubMed Abstract available

IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
Catheter Cardiovasc Interv. 2021;98:E540-E547.
PubMed Abstract available

BRINKMANN C, Abdel-Wahab M, Bedogni F, Bhadra OD, et al
Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter study.
Catheter Cardiovasc Interv. 2021;98:756-764.
PubMed Abstract available

GARCIA-SAYAN E, Raghunathan D, Li FM, Dhoble A, et al
Initial experience with the fourth generation MitraClip: Outcomes, procedural aspects, and considerations for device selection.
Catheter Cardiovasc Interv. 2021;98:E626-E636.
PubMed Abstract available

TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
Catheter Cardiovasc Interv. 2021;98:678-688.
PubMed Abstract available

September 2021

CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
PubMed Abstract available

ELBADAWI A, Mahta D, Elgendy IY, Dang AT, et al
Trends in utilization, outcomes, and readmissions after transcatheter mitral valve replacement.
Catheter Cardiovasc Interv. 2021 Sep 27. doi: 10.1002/ccd.29963.
PubMed Abstract available

LEE DU, Han J, Fan GH, Hastie DJ, et al
The clinical impact of chronic liver disease in patients undergoing transcatheter and surgical aortic valve replacement: Systematic analysis of the 2011-2017 US hospital database.
Catheter Cardiovasc Interv. 2021 Sep 25. doi: 10.1002/ccd.29952.
PubMed Abstract available

OKUYA Y, Moussa ID
Coronary bypass graft surgery accentuates proximal coronary disease progression!
Catheter Cardiovasc Interv. 2021;98:492.
PubMed

ALKHOULI M, Jneid H
Optimal management of acute decompensated aortic stenosis.
Catheter Cardiovasc Interv. 2021;98:613-614.
PubMed

HARA H, Ono M, Kawashima H, Kogame N, et al
Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
Catheter Cardiovasc Interv. 2021;98:E379-E387.
PubMed Abstract available

FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
Changes in surgical revascularization strategy after fractional flow reserve.
Catheter Cardiovasc Interv. 2021;98:E351-E355.
PubMed Abstract available

PETRI N, Lengenfelder B, Voelker W, Nordbeck P, et al
Interventional closure of aortomitral perforation after TAVR: A case report.
Catheter Cardiovasc Interv. 2021;98:E483-E485.
PubMed Abstract available

WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
Catheter Cardiovasc Interv. 2021;98:483-491.
PubMed Abstract available

MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
Catheter Cardiovasc Interv. 2021;98:470-480.
PubMed Abstract available

MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
Catheter Cardiovasc Interv. 2021;98:447-457.
PubMed Abstract available

August 2021

BRUGGER N, Kassar M, Siontis GCM, Widmer S, et al
Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
Catheter Cardiovasc Interv. 2021 Aug 18. doi: 10.1002/ccd.29916.
PubMed Abstract available

GARCIA-GOMEZ M, Delgado-Arana JR, Halim J, De Marco F, et al
Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients.
Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29923.
PubMed Abstract available

MINHA S, Yarkoni Y, Segev A, Finkelstein A, et al
Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation-A retrospective cohort study.
Catheter Cardiovasc Interv. 2021 Aug 4. doi: 10.1002/ccd.29891.
PubMed Abstract available

GUDDETI RR, Pajjuru VS, Walters RW, Garcia SA, et al
Impact of gender on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter edge-to-edge mitral valve repair: Analysis from the National Readmission Database.
Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29887.
PubMed Abstract available

BELARDI JA, Lamelas PM
New TAVR item added to cart for large scale clinical testing.
Catheter Cardiovasc Interv. 2021;98:380-381.
PubMed

POSTALIAN A, Krajcer Z
Individualizing risk assessment for conduction system injury after alcohol septal ablation.
Catheter Cardiovasc Interv. 2021;98:401-402.
PubMed

FRANZONE A, Esposito G
Transcatheter aortic valve thrombosis: The more we see the more we know.
Catheter Cardiovasc Interv. 2021;98:363-364.
PubMed

GAO W, Chen Y, Yang H, Yao K, et al
Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
Catheter Cardiovasc Interv. 2021;98:E254-E261.
PubMed Abstract available

GRINES CL, Klein AJ, Bauser-Heaton H, Alkhouli M, et al
Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease.
Catheter Cardiovasc Interv. 2021;98:277-294.
PubMed Abstract available

RIMMAUDO F, Angelini G, Condello I
Thrombocytopenia after TAVI in patients with low body mass index.
Catheter Cardiovasc Interv. 2021;98:E329-E331.
PubMed

KREUTZER J, Armstrong AK, Rome JJ, Zellers TM, et al
Comparison of the investigational device exemption and post-approval trials of the Melody transcatheter pulmonary valve.
Catheter Cardiovasc Interv. 2021;98:E262-E274.
PubMed Abstract available

GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
Catheter Cardiovasc Interv. 2021;98:E197-E204.
PubMed Abstract available

QURESHI WT, Parker M, Walker J, Kakouros N, et al
Equipment entrapment during redo-TAVR with successful BASILICA procedure.
Catheter Cardiovasc Interv. 2021;98:E320-E323.
PubMed Abstract available

HERNANDEZ-ENRIQUEZ M, Boudou N, Belle L
Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?"
Catheter Cardiovasc Interv. 2021;98:411-412.
PubMed

JURADO-ROMAN A, Gonzalvez A, Jimenez-Valero S, Galeote G, et al
What have we learnt from the use of papyrus covered stent in France and Spain?
Catheter Cardiovasc Interv. 2021;98:410.
PubMed

AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
Catheter Cardiovasc Interv. 2021;98:225-235.
PubMed Abstract available

July 2021

STAUDACHER DL, Braxmeier K, Stachon P, Hilgendorf I, et al
Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications.
Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29885.
PubMed Abstract available

VAN MIEGHEM NM, Windecker S, Manoharan G, Bosmans J, et al
Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29889.
PubMed Abstract available

URENA M, Lemann T, Chong-Nguyen C, Brochet E, et al
Causes and predictors of mortality after transcatheter mitral valve implantation in patients with severe mitral annulus calcification.
Catheter Cardiovasc Interv. 2021 Jul 15. doi: 10.1002/ccd.29874.
PubMed Abstract available

OGUZ D, Padang R, Pislaru SV, Nkomo VT, et al
Clinical predictors and impact of postoperative mean gradient on outcome after transcatheter edge-to-edge mitral valve repair.
Catheter Cardiovasc Interv. 2021 Jul 10. doi: 10.1002/ccd.29867.
PubMed Abstract available

CILINGIROGLU M, Okutucu S
TAVR in patients with end stage liver and renal disease: Lifesaving and increasing transplant eligibility.
Catheter Cardiovasc Interv. 2021;98:168-169.
PubMed

LEE HS, Kang J, Park KW, Ki YJ, et al
Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
Catheter Cardiovasc Interv. 2021;98:E43-E52.
PubMed Abstract available

SOGABE K, Koide M, Fukui K, Kato Y, et al
Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
Catheter Cardiovasc Interv. 2021;98:E35-E42.
PubMed Abstract available

BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
Catheter Cardiovasc Interv. 2021;98:24-32.
PubMed Abstract available

SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
Catheter Cardiovasc Interv. 2021;98:66-75.
PubMed Abstract available

BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
Catheter Cardiovasc Interv. 2021;98:57-65.
PubMed Abstract available

June 2021

ROTTLANDER D, Godde M, Degen H, Ogutcu A, et al
Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography.
Catheter Cardiovasc Interv. 2021 Jun 25. doi: 10.1002/ccd.29824.
PubMed Abstract available

FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
Prognostic impact of echocardiographic mean transvalvular gradients in patients with aortic stenosis and low flow undergoing transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2021 Jun 17. doi: 10.1002/ccd.29840.
PubMed Abstract available

NICOLAS J, Guedeney P, Claessen BE, Mehilli J, et al
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.
Catheter Cardiovasc Interv. 2021 Jun 12. doi: 10.1002/ccd.29807.
PubMed Abstract available

SALEEM S, Ullah W, Syed MA, Megaly M, et al
Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
Catheter Cardiovasc Interv. 2021 Jun 10. doi: 10.1002/ccd.29789.
PubMed Abstract available

GRINES CL, Leach C
Acute myocardial infarction related cardiogenic shock: How important is vascular access site?
Catheter Cardiovasc Interv. 2021;97:1367-1368.
PubMed

COSTELLO BT, Krajcer Z
Editorial Comments for: "Transcatheter valve-in-valve implantation versus surgical redo aortic root replacement in patients with degenerated freestyle aortic bioprosthesis".
Catheter Cardiovasc Interv. 2021;97:1479-1480.
PubMed

KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
Catheter Cardiovasc Interv. 2021;97:1399-1401.
PubMed Abstract available

DING PYJ, Webber B, Ormiston J, Webster M, et al
Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
Catheter Cardiovasc Interv. 2021;97:E951-E955.
PubMed Abstract available

IMAMURA T, Narang N
Improving clinical outcomes following MitraClip.
Catheter Cardiovasc Interv. 2021;97:E1053.
PubMed

May 2021

LIM DS, Smith RL, Zahr F, Dhoble A, et al
Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation.
Catheter Cardiovasc Interv. 2021 May 18. doi: 10.1002/ccd.29749.
PubMed Abstract available

LIU X, Pu Z, Lim DS, Wang J, et al
Transcatheter mitral valve repair in a high-surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly Transcatheter Repair device-First in man implantation in China.
Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29687.
PubMed Abstract available

TARANTINI G, Fraccaro C
Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction.
Catheter Cardiovasc Interv. 2021;97:1268-1269.
PubMed

ADUSUMALLI S, Dautov R
An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
Catheter Cardiovasc Interv. 2021;97:1213-1217.
PubMed Abstract available

KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
Dedicated plug based closure for large bore access -The MARVEL prospective registry.
Catheter Cardiovasc Interv. 2021;97:1270-1278.
PubMed Abstract available

BELHAJ SOULAMI R, Castro M, Haigron P, Verhoye JP, et al
Computer-assisted valve in valve in a deteriorated Mosaic valve using a library of bioprostheses.
Catheter Cardiovasc Interv. 2021;97:E893-E896.
PubMed Abstract available

SAAD AM, Kassis N, Gad MM, Abdelfattah O, et al
Impact of atrial fibrillation on outcomes following MitraClip: A contemporary population-based analysis.
Catheter Cardiovasc Interv. 2021;97:1252-1256.
PubMed Abstract available

ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
An algorithmic approach to balloon-uncrossable coronary lesions.
Catheter Cardiovasc Interv. 2021;97:E817-E825.
PubMed Abstract available

CAI X, Tian F, Jing J, Jin Q, et al
Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
PubMed Abstract available

HU P, Sun Y, Li CL, Jin R, et al
A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
PubMed Abstract available

April 2021

MORENO R, Baz JA, Moreu J, Berenguer A, et al
Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra-annular device. The Spanish Allegra valve-in-valve (SAVIV) registry.
Catheter Cardiovasc Interv. 2021 Apr 23. doi: 10.1002/ccd.29742.
PubMed Abstract available

CHANDRA P, Jose J, Mattummal S, Mahajan AU, et al
Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial.
Catheter Cardiovasc Interv. 2021 Apr 20. doi: 10.1002/ccd.29733.
PubMed Abstract available

MARTINEZ-GOMEZ E, McInerney A, Tirado-Conte G, de Agustin JA, et al
Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: A systematic review.
Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29703.
PubMed Abstract available

OKUNO T, Heg D, Lanz J, Praz F, et al
Heart valve sizing and clinical outcomes in patients undergoing transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29700.
PubMed Abstract available

PANCHAL HB, Stone GW, Saxena A, Bursac Z, et al
In-hospital outcomes after transcatheter edge-to-edge mitral valve repair in patients with chronic kidney disease: An analysis from the 2010-2016 National inpatient sample.
Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29712.
PubMed Abstract available

COSTA G, D'Errigo P, Rosato S, Valvo R, et al
Long-term outcomes of self-expanding versus balloon-expandable transcatheter aortic valves: Insights from the OBSERVANT study.
Catheter Cardiovasc Interv. 2021 Apr 13. doi: 10.1002/ccd.29701.
PubMed Abstract available

CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
PubMed Abstract available

FALASCONI G, Melillo F, Pannone L, Adamo M, et al
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
PubMed Abstract available

IRIART X, Guerin P, Jalal Z, Thambo JB, et al
Edge to edge repair using a MitraClip for severe tricuspid valve regurgitation after a Mustard operation.
Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29681.
PubMed Abstract available

March 2021

BOEDER NF, Bayer M, Dorr O, Nef HM, et al
Fusion imaging guided implantation of a Tricento transcatheter heart valve for severe tricuspid regurgitation.
Catheter Cardiovasc Interv. 2021 Mar 23. doi: 10.1002/ccd.29587.
PubMed Abstract available

KABAHIZI A, Sheikh AS, Williams T, Tanseco K, et al
Elective versus urgent in-hospital transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2021 Mar 13. doi: 10.1002/ccd.29638.
PubMed Abstract available

KITAMURA M, Fam NP, Braun D, Ruf T, et al
12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation.
Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29583.
PubMed Abstract available

February 2021

MOUYEN T, Manigold T, Collet JP, Durand E, et al
Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
PubMed Abstract available

ESTEVEZ-LOUREIRO R, Shuvy M, Taramasso M, Benito-Gonzalez T, et al
Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry).
Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29552.
PubMed Abstract available

HALE SM, Jessen M, Banerjee S, Kumbhani DJ, et al
Successful transcatheter treatment for very late migration of a transcatheter aortic valve into the left ventricular outflow tract.
Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29547.
PubMed Abstract available

SA MPBO, Simonato M, Van den Eynde J, Cavalcanti LRP, et al
Balloon versus self-expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: A meta-analysis of observational studies.
Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29538.
PubMed Abstract available

SEJR-HANSEN M, Christiansen EH, Ahmad Y, Vendrik J, et al
Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29518.
PubMed Abstract available

KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
In-hospital outcomes of transcatheter mitral valve repair in patients with and without end stage renal disease: A national propensity match study.
Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29517.
PubMed Abstract available

January 2021

MYAT A, Mouy F, Buckner L, Cockburn J, et al
Survival relative to pacemaker status after transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29498.
PubMed Abstract available

QINTAR M, Wang DD, O'Neill WW, O'Neill B, et al
Non-coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of "Eustachian ridge?"
Catheter Cardiovasc Interv. 2021 Jan 25. doi: 10.1002/ccd.29461.
PubMed Abstract available

MEIJERINK F, Koch KT, de Winter RJ, Robbers-Visser D, et al
Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome.
Catheter Cardiovasc Interv. 2021 Jan 18. doi: 10.1002/ccd.29464.
PubMed Abstract available

NIJENHUIS VJ, Meyer A, Brouwer J, Mahmoodi BK, et al
The effect of transcatheter aortic valve implantation approaches on mortality.
Catheter Cardiovasc Interv. 2021 Jan 14. doi: 10.1002/ccd.29456.
PubMed Abstract available

December 2020

TANSECO KV, Alsanjari O, Cockburn J, Hildick-Smith D, et al
Amplatzer device closure of femoral pseudoaneurysm after transcatheter aortic valve implantation: An alternative to surgical repair.
Catheter Cardiovasc Interv. 2020 Dec 22. doi: 10.1002/ccd.29424.
PubMed Abstract available

ANCONA MB, Beneduce A, Romano V, Buzzatti N, et al
Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management.
Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29432.
PubMed Abstract available

BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
PubMed Abstract available

AMAT-SANTOS IJ, Santos-Martinez S, Conradi L, Taramasso M, et al
Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study.
Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29423.
PubMed Abstract available

November 2020

LABIN JE, Saggar R, Yang EH, Lluri G, et al
Left main coronary artery compression in pulmonary hypertension.
Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
PubMed Abstract available

BAEKKE PS, Jorgensen TH, Sondergaard L
Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29403.
PubMed Abstract available

SUGIURA A, Weber M, Tabata N, Goto T, et al
Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation.
Catheter Cardiovasc Interv. 2020 Nov 19. doi: 10.1002/ccd.29390.
PubMed Abstract available

BENETOS G, Karmpalioti M, Drakopoulou M, Stathogiannis K, et al
One-year clinical and echocardiographic outcomes of direct implantation of a self-expanding valve.
Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29389.
PubMed Abstract available

ALARFAJ M, Jain T, Krepp J
Transcatheter mitral valve thrombosis: A case report and literature review.
Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29374.
PubMed Abstract available

SAYAH N, Simon F, Garceau P, Ducharme A, et al
Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair.
Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29365.
PubMed Abstract available

CASENGHI M, Gorla R, Popolo Rubbio A, De Marco F, et al
One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system.
Catheter Cardiovasc Interv. 2020 Nov 6. doi: 10.1002/ccd.29353.
PubMed Abstract available

October 2020

ABU KHADIJA H, Ayyad O, Haberman D, Gandelman G, et al
Contemporary transcatheter aortic valve implantation related thrombocytopenia.
Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29325.
PubMed Abstract available

KORBER MI, Friedrichs KP, Aydin F, Pfister R, et al
Impact of cleft-like indentations on procedural outcome of percutaneous edge-to-edge mitral valve repair.
Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29286.
PubMed Abstract available

September 2020

HOSHI T, Hiraya D, Sato A, Ieda M, et al
Potential risk of perioperative thromboembolism in patients with antiphospholipid syndrome who undergo transcatheter aortic valve implantation: A case series.
Catheter Cardiovasc Interv. 2020 Sep 25. doi: 10.1002/ccd.29300.
PubMed Abstract available

MORITA Y, Endo A, Tanabe K
Papillary muscle rupture after transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29252.
PubMed Abstract available

HASE H, Yoshijima N, Yanagisawa R, Tanaka M, et al
Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry.
Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29259.
PubMed Abstract available

IMAMURA T
How to prevent thrombosis following transcatheter aortic valve replacement during durable left ventricular assist device supports.
Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29268.
PubMed

SHARMA SP, Chaudhary R, Ghuneim A, Harder W, et al
Carotid access for transcatheter aortic valve replacement: A meta-analysis.
Catheter Cardiovasc Interv. 2020 Sep 5. doi: 10.1002/ccd.29244.
PubMed Abstract available

August 2020

ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
Short-term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States.
Catheter Cardiovasc Interv. 2020 Aug 28. doi: 10.1002/ccd.29189.
PubMed Abstract available

FEGHALY J, Muskula P, Kumar S, Helmy T, et al
Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
PubMed Abstract available

KASSIS N, Saad AM, Ahuja KR, Gad MM, et al
Impact of thoracic aortic aneurysm on outcomes of transcatheter aortic valve replacement: A nationwide cohort analysis.
Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29195.
PubMed Abstract available

BIANCARI F, Pykari J, Savontaus M, Laine M, et al
Early and late pace-maker implantation after transcatheter and surgical aortic valve replacement.
Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29177.
PubMed Abstract available

July 2020

YAMAMOTO M, Otsuka T, Shimura T, Yamaguchi R, et al
Clinical risk model for predicting 1-year mortality after transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2020 Jul 30. doi: 10.1002/ccd.29130.
PubMed Abstract available

RAHEJA H, Ahuja KR, Nazir S, Saad AM, et al
Association of baseline kidney disease with outcomes of transcatheter mitral valve repair by MitraClip.
Catheter Cardiovasc Interv. 2020 Jul 23. doi: 10.1002/ccd.29129.
PubMed Abstract available

SHEIKH MA, Deo SV, Riaz H, Raza S, et al
Safety-net hospitals versus non-safety centers and clinical outcomes after trans-catheter aortic valve replacement.
Catheter Cardiovasc Interv. 2020 Jul 18. doi: 10.1002/ccd.29123.
PubMed Abstract available

SATHANANTHAN J, Lauck S, Polderman J, Yu M, et al
Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29124.
PubMed Abstract available

CHIEW KLX, Lim PO
Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.
Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29099.
PubMed Abstract available

COSTA G, Ihlemann N, Sondergaard L, De Backer O, et al
Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm.
Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29108.
PubMed Abstract available

COSTA G, Bieliauskas G, Fukutomi M, Ihlemann N, et al
Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program.
Catheter Cardiovasc Interv. 2020 Jul 1. doi: 10.1002/ccd.29117.
PubMed Abstract available

June 2020

ROMEO FJ, Seropian IM, Chiabrando JG, Raleigh JV, et al
Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2020 Jun 28. doi: 10.1002/ccd.29067.
PubMed Abstract available

YOUNG L, Kapadia S, Khatri J
Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.
Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29127.
PubMed

MATSUDA Y, Nai Fovino L, Giacoppo D, Scotti A, et al
Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis.
Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29105.
PubMed Abstract available

SATHANANTHAN J, Green P, Finn M, Wood DA, et al
Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.28981.
PubMed Abstract available

TANG L, Sorajja P, Mooney M, Garberich R, et al
Transcatheter aortic valve replacement in patients with severe comorbidities: A retrospective cohort study.
Catheter Cardiovasc Interv. 2020 Jun 8. doi: 10.1002/ccd.29063.
PubMed Abstract available

MURPHY AC, Koshy AN, Cameron W, Horrigan M, et al
Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.
Catheter Cardiovasc Interv. 2020 Jun 4. doi: 10.1002/ccd.28969.
PubMed Abstract available

May 2020

SIQUEIRA DA, Simonato M, Ramos AA, Bignoto T, et al
Mid- to long-term clinical and echocardiographic outcomes after transcatheter aortic valve replacement with a new-generation, self-expandable system.
Catheter Cardiovasc Interv. 2020 May 23. doi: 10.1002/ccd.28999.
PubMed Abstract available

LI SX, Patel NK, Flannery LD, Cigarroa RJ, et al
Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease.
Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28989.
PubMed Abstract available

BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
PubMed Abstract available

April 2020

SUN Y, Li J, Li G, Fan R, et al
Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28899.
PubMed Abstract available

BIGNOTO TC, Le Bihan D, de Mattos Barretto RB, de Oliveira Ramos AI, et al
Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
Catheter Cardiovasc Interv. 2020 Apr 16. doi: 10.1002/ccd.28905.
PubMed Abstract available

February 2020

DALL'ARA G, Tumscitz C, Grotti S, Santarelli A, et al
Contemporary balloon aortic valvuloplasty: Changing indications and refined technique.
Catheter Cardiovasc Interv. 2020 Feb 25. doi: 10.1002/ccd.28807.
PubMed Abstract available

January 2020

ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
PubMed Abstract available

December 2019

KWOK CS, Amin AP, Shah B, Kinnaird T, et al
Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
PubMed Abstract available

November 2019

MANGELS D, Penny W, Reeves R
Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: